监测美国RSV预防产品有效性的框架

Lauren E Roper1, Ruth Link-Gelles1, Diya Surie1

  • 1National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.

Vaccine
|January 4, 2025
PubMed
概括

疾病预防控制中心 (CDC) 正在评估新的呼吸道同胞病毒 (RSV) 免疫的实际有效性,包括疫苗和nirsevimab,以告知婴儿和老年人的预防策略.